FDA Proposes Coal Tar/Menthol Addition To OTC Dandruff Monograph
This article was originally published in The Tan Sheet
Executive Summary
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products would be amended to include a specific combination of coal tar and menthol under a proposed rule published by FDA in the Federal Register Dec. 9
You may also be interested in...
OTC dandruff monograph
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products is being amended to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff, FDA says in a March 6 Federal Register notice. The regulation is effective April 5, 2007. The agency solicited comments on the proposed amendment in late 2005, but did not receive any responses (1"The Tan Sheet" Dec. 12, 2005, p. 6)...
OTC dandruff monograph
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products is being amended to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff, FDA announces in a March 6 Federal Register notice. The regulation is effective April 5. The agency solicited comments on the proposed amendment in late 2005, but did not receive any responses (1"The Rose Sheet" Dec. 12, 2005, p. 6)...
OTC dandruff monograph
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products is being amended to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff, FDA says in a March 6 Federal Register notice. The regulation is effective April 5, 2007. The agency solicited comments on the proposed amendment in late 2005, but did not receive any responses (1"The Tan Sheet" Dec. 12, 2005, p. 6)...